elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q29622818-44DB6159-3AB7-4D6D-B7C7-6A762733B853
Q29622818-44DB6159-3AB7-4D6D-B7C7-6A762733B853
BestRank
Statement
http://www.wikidata.org/entity/statement/Q29622818-44DB6159-3AB7-4D6D-B7C7-6A762733B853
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
P921
Q29622818-44DB6159-3AB7-4D6D-B7C7-6A762733B853
BestRank
Statement
http://www.wikidata.org/entity/statement/Q29622818-44DB6159-3AB7-4D6D-B7C7-6A762733B853
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82630af7e1151e88e8ae34ab9d05aea66cb2f3b3
P921
antibody